Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Crile G., Jr, Antunez A. R., Esselstyn C. B., Jr, Hawk W. A., Skillern P. G. The advantages of subtotal thyroidectomy and suppression of TSH in the primary treatment of papillary carcinoma of the thyroid. Cancer. 1985 Jun 1;55(11):2691–2697. doi: 10.1002/1097-0142(19850601)55:11<2691::aid-cncr2820551126>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- DeGroot L. J., Kaplan E. L., McCormick M., Straus F. H. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990 Aug;71(2):414–424. doi: 10.1210/jcem-71-2-414. [DOI] [PubMed] [Google Scholar]
- Dulgeroff A. J., Hershman J. M. Medical therapy for differentiated thyroid carcinoma. Endocr Rev. 1994 Aug;15(4):500–515. doi: 10.1210/edrv-15-4-500. [DOI] [PubMed] [Google Scholar]
- Hedinger C., Williams E. D., Sobin L. H. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer. 1989 Mar 1;63(5):908–911. doi: 10.1002/1097-0142(19890301)63:5<908::aid-cncr2820630520>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
- Johansen K., Woodhouse N. J., Odugbesan O. Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer. J Nucl Med. 1991 Feb;32(2):252–254. [PubMed] [Google Scholar]
- Maxon H. R., 3rd, Englaro E. E., Thomas S. R., Hertzberg V. S., Hinnefeld J. D., Chen L. S., Smith H., Cummings D., Aden M. D. Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med. 1992 Jun;33(6):1132–1136. [PubMed] [Google Scholar]
- Mazzaferri E. L., Jhiang S. M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994 Nov;97(5):418–428. doi: 10.1016/0002-9343(94)90321-2. [DOI] [PubMed] [Google Scholar]
- Mazzaferri E. L. Management of a solitary thyroid nodule. N Engl J Med. 1993 Feb 25;328(8):553–559. doi: 10.1056/NEJM199302253280807. [DOI] [PubMed] [Google Scholar]
- Mazzaferri E. L. Papillary and follicular thyroid cancer: a selective approach to diagnosis and treatment. Annu Rev Med. 1981;32:73–91. doi: 10.1146/annurev.me.32.020181.000445. [DOI] [PubMed] [Google Scholar]
- Mazzaferri E. L., Young R. L., Oertel J. E., Kemmerer W. T., Page C. P. Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) 1977 May;56(3):171–196. [PubMed] [Google Scholar]
- Mazzaferri E. L., Young R. L. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med. 1981 Mar;70(3):511–518. doi: 10.1016/0002-9343(81)90573-8. [DOI] [PubMed] [Google Scholar]
- Varma V. M., Beierwaltes W. H., Nofal M. M., Nishiyama R. H., Copp J. E. Treatment of thyroid cancer. Death rates after surgery and after surgery followed by sodium iodide I-131. JAMA. 1970 Nov 23;214(8):1437–1442. doi: 10.1001/jama.214.8.1437. [DOI] [PubMed] [Google Scholar]
- WOOLNER L. B., BEAHRS O. H., BLACK B. M., McCONAHEY W. M., KEATING F. R., Jr Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a thirty year period. Am J Surg. 1961 Sep;102:354–387. doi: 10.1016/0002-9610(61)90527-x. [DOI] [PubMed] [Google Scholar]
- Wong J. B., Kaplan M. M., Meyer K. B., Pauker S. G. Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective. Endocrinol Metab Clin North Am. 1990 Sep;19(3):741–760. [PubMed] [Google Scholar]
- Young R. L., Mazzaferri E. L., Rahe A. J., Dorfman S. G. Pure follicular thyroid carcinoma: impact of therapy in 214 patients. J Nucl Med. 1980 Aug;21(8):733–737. [PubMed] [Google Scholar]